SCHEMBL24512243

SCHEMBL24512243

Cc1ccc(-c2nnc(-c3ccccc3)[nH]2)cc1S(=O)(=O)N1C2CCC1COC2

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.41
CNR2 P34972 5/20 0.41
MAOB P27338 1/20 0.40
MAPT P10636 4/20 0.38
BRD4 O60885 4/20 0.38
BRD2 P25440 4/20 0.38
BRD3 Q15059 4/20 0.38
POLB P06746 3/20 0.37
AKR1C3 P42330 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29717158 1.00 CNR1 (0.41) CNR1CNR2MAOBMAPTBRD4
SCHEMBL24512347 0.92 CNR1 (0.37) CNR1CNR2MAOBMAPTBRD4
SCHEMBL29717135 0.85 CNR1 (0.48) CNR1CNR2MAPTBRD4BRD2
SCHEMBL24512334 0.85 CNR1 (0.48) CNR1CNR2MAPTBRD4BRD2
SCHEMBL24512121 0.85 CNR1 (0.46) CNR1CNR2MAOBMAPTBRD4
SCHEMBL24512359 0.85 CNR1 (0.46) CNR1CNR2MAOBMAPTBRD4
SCHEMBL29717111 0.80 CNR1 (0.64) CNR1CNR2MAPTBRD4BRD2
SCHEMBL24512245 0.80 CNR1 (0.64) CNR1CNR2MAPTBRD4BRD2
SCHEMBL24512273 0.79 CNR1 (0.46) CNR1CNR2MAPTBRD4BRD2
SCHEMBL30899272 0.79 CNR1 (0.46) CNR1CNR2MAPTBRD4BRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022125989-A1 COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS SCRIPPS RESEARCH INSTITUTE, THE (US) 2022-06-16 WO disclosed